MedPath

UNIVERSITY OF WASHINGTON

UNIVERSITY OF WASHINGTON logo
🇺🇸United States
Ownership
Private
Established
1861-01-01
Employees
10K
Market Cap
-
Website
https://www.cs.washington.edu
dailygazette.com
·

Sugary drinks cause millions of cases of diabetes and heart disease yearly

Sugary drinks cause millions of new diabetes and heart disease cases annually, with significant impacts in developing countries. Research highlights the need for global interventions like public health campaigns and taxes to reduce consumption and its health consequences.
genengnews.com
·

From Promise to Practice: Danaher Gathers Visionaries to Discuss AI-Driven R&D

Eric Topol, MD, highlighted AI's potential in healthcare at Danaher's summit, emphasizing its role in improving diagnostics, patient care, and drug discovery. Despite challenges like ethical guidelines and trust, AI's rapid advancement, exemplified by tools like AlphaFold and ChatGPT, is transforming medicine. Experts advocate for embracing AI to enhance healthcare outcomes.
now.tufts.edu
·

New Study Links Millions of Diabetes and Heart Disease Cases to Sugar-Sweetened Beverages

A Tufts University study links 2.2M new type 2 diabetes and 1.2M cardiovascular disease cases annually to sugar-sweetened beverages, with significant impacts in Sub-Saharan Africa, Latin America, and the Caribbean. Colombia, Mexico, and South Africa are notably affected. Researchers urge global interventions to reduce consumption.
news-medical.net
·

Sugary beverages contribute to millions of diabetes and cardiovascular disease cases annually

A Tufts University study in Nature Medicine links 2.2M new type 2 diabetes and 1.2M cardiovascular disease cases annually to sugar-sweetened beverages. Developing countries, especially in Sub-Saharan Africa and Latin America, are heavily impacted. The study calls for global interventions like public health campaigns, advertising regulation, and taxes to reduce consumption and its health consequences.
nbcnews.com
·

Alcohol and cancer: What to know about the alarming links

U.S. surgeon general's report links alcohol to seven cancer types, urging warning labels on drinks. Experts emphasize no safe alcohol level, as it damages DNA and increases cancer risk. Alcohol is a top preventable cancer cause, with risks varying by consumption level. Reducing drinking can lower risks, but reversing damage takes years.
hcplive.com
·

Endocrinology Month in Review: December 2024

December 2024 saw significant endocrinology updates: tirzepatide outperformed semaglutide in weight loss, mifepristone reduced HbA1c in T2D, FDA approved crinecerfont for CAH and a generic GLP-1 RA for T2D. Diabetes Dialogue podcast highlighted diabetes tech and therapy advancements.
spokesman.com
·

A University of Washington study on menopause revealed health disparities between rural and urban women

Research from the University of Washington highlights that rural women experience more menopause symptoms than urban counterparts, attributed to limited healthcare access. A survey revealed rural women report higher rates of mood swings, pain, and urinary issues. The study emphasizes the need for better menopause education and treatment options to address health disparities.
urologytimes.com
·

Sarah Psutka, MD, on phase 3 trial of padeliporfin VTP therapy in UTUC

The phase 3 ENLIGHTED trial investigates padeliporfin VTP's safety and efficacy for low-grade upper tract urothelial carcinoma, aiming to preserve the kidney. Led by Sarah P. Psutka, MD, MSc, it targets a complete response rate, showing promising early results with minimal toxicity.
oncnursingnews.com
·

Study of Sacituzumab Govitecan Misses OS End Point in Pretreated Urothelial Carcinoma

Sacituzumab govitecan did not significantly improve overall or progression-free survival in advanced urothelial carcinoma compared to chemotherapy, despite a higher objective response rate. The phase 3 TROPiCS-04 study missed its primary endpoint, indicating limited efficacy over standard treatments.
msnbc.com
·

2024 was a good year for medical progress. But that alone won't save us.

2024 saw HIV prevention advancements, a U.S. obesity rate drop, and the murder of an insurance CEO highlighting care denials. Lenacapavir was a breakthrough for HIV prevention, while GLP-1s impacted obesity. Insurance practices and political interference in healthcare faced scrutiny, alongside public health challenges like disease comebacks and vaccine misinformation.
© Copyright 2025. All Rights Reserved by MedPath